- NCIt
- C132146
Loading cancer entity…
Loading cancer entity…
Clinical trials
900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (101)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07126665 | A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors | recruiting | Phase 1 / Phase 2 | 116 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07130383 | A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors | recruiting | Phase 2 | 210 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Nov 18, 2025 |
| NCT05023993 | The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer | active not recruiting | N/A | 20 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT04989556 | Technology-Enhanced Palliative Care for Advanced Cancer Patients | active not recruiting | N/A | 119 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06022965 | Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial | recruiting | N/A | 216 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07196579 | Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 | 30 | TCRx Therapeutics Co.LtdINDUSTRY | 1 | Sep 29, 2025 | clinicaltrials |
| NCT05138991 | Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors | active not recruiting | N/A | 149 | City of Hope Medical CenterOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05246670 | PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy | active not recruiting | Phase 2 | 88 | Academic and Community Cancer Research UnitedOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06985355 | A Study of MHB046C Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 200 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Sep 18, 2025 | clinicaltrials |
| NCT06328686 | Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases | recruiting | Early Phase 1 | 10 | Emory UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07170293 | Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors | recruiting | Phase 2 | 15 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04632108 | A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 199 | Jiangsu Aosaikang Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07151807 | Serum IGF-1 and IGF-1Ec in Malignancy Assessment(SIGMA) | active not recruiting | — | 100 | Çanakkale Onsekiz Mart UniversityOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07124195 | Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting | not yet recruiting | Phase 3 | 126 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT07114627 | Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients(ESCAPE) | recruiting | — | 66 | Erasmus Medical CenterOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07110363 | A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer | not yet recruiting | Phase 1 | 58 | Biotroy TherapeuticsINDUSTRY | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07092748 | A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors | recruiting | Phase 1 | 110 | Zhejiang Hisun Pharmaceutical Co. Ltd.INDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT06710158 | Study of SC-102 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 120 | Tianjin ConjuStar Biologics Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07088588 | Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors | not yet recruiting | Phase 1 | 105 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT07077252 | Phase I/II Study of SCTB39G in Advanced Solid Tumours | not yet recruiting | Phase 1 / Phase 2 | 30 | Sinocelltech Ltd.INDUSTRY | 1 | Jul 22, 2025 | clinicaltrials |
| NCT06666270 | Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07050641 | Phase I/II Study of SCTB39-1 in Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 110 | Sinocelltech Ltd.INDUSTRY | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07051161 | Impact of Interventional Endoscopy on Quality of Life in Patients With Acute Respiratory Distress Due to Tumor Compression or Obstruction of the Lower Respiratory Tract(ENDoRA) | not yet recruiting | — | 60 | University Hospital, GrenobleOTHER | 0 | Jul 4, 2025 | clinicaltrials |
| NCT07045454 | A Study of MHB118C Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 200 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07030478 | A Study to Evaluate the Safety and Tolerability of EP0089 | not yet recruiting | Phase 1 / Phase 2 | 190 | Ellipses PharmaINDUSTRY | 0 | Jun 22, 2025 | clinicaltrials |
| NCT07002502 | Immune Modulation With PRaG-1 Treatment | not yet recruiting | Phase 2 | 19 | Second Affiliated Hospital of Soochow UniversityOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT06999538 | Real-life Performance Evaluation of the LiFlow X-ray Platform(LiFE) | not yet recruiting | — | 400 | University Hospital, AngersOTHER_GOV | 0 | May 31, 2025 | clinicaltrials |
| NCT06939764 | Application of the sG8 Scale in Real-World Geriatric Oncology Patients | not yet recruiting | — | 346 | Sichuan Cancer Hospital and Research InstituteOTHER | 0 | Apr 23, 2025 | clinicaltrials |
| NCT05477849 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors | recruiting | Phase 1 | 30 | Shanghai Virogin Biotech Co., Ltd.INDUSTRY | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04877717 | A Study of SHR-A1904 in Patients With Advanced Solid Cancer | active not recruiting | Phase 1 | 107 | Shanghai Hengrui Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06894082 | Study of Radiology Manipulator Work Validation by the Radiologist(Cimer) | recruiting | — | 87 | Institut Paoli-CalmettesOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06883539 | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. | recruiting | Phase 1 | 24 | LaunXP Biomedical Co., Ltd.INDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06730386 | A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors | recruiting | Phase 1 | 100 | AkesoINDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT05749627 | Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors | recruiting | N/A | 20 | The First Affiliated Hospital of Nanchang UniversityOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06464055 | A Study of GQ1010 in Subjects With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 260 | GeneQuantum Healthcare (Suzhou) Co., Ltd.INDUSTRY | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06713148 | Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 42 | Fudan UniversityOTHER | 0 | Feb 6, 2025 | clinicaltrials |
| NCT06718946 | Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors | recruiting | Early Phase 1 | 38 | Fudan UniversityOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT03791112 | A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor | active not recruiting | Phase 1 | 54 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jan 27, 2025 | clinicaltrials |
| NCT06600022 | Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours. | recruiting | Phase 1 / Phase 2 | 441 | Sinocelltech Ltd.INDUSTRY | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06763159 | A Study of HS-20124 in Patients with Advanced Solid Tumors | recruiting | Phase 1 | 450 | Hansoh BioMedical R&D CompanyINDUSTRY | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06728189 | A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors | recruiting | Phase 1 | 13 | Peking University Cancer Hospital & InstituteOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06726564 | A Study of MT027 in Patients with Pleural Malignant Tumors | recruiting | Phase 1 | 18 | Suzhou Maximum Bio-tech Co., Ltd.INDUSTRY | 1 | Dec 10, 2024 | clinicaltrials |
| NCT06702566 | The Effect of Serum Ferritin in irAE | recruiting | N/A | 1,500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06697665 | An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours | recruiting | Early Phase 1 | 10 | Suzhou BlueHorse Therapeutics Co., Ltd.INDUSTRY | 1 | Nov 20, 2024 | clinicaltrials |
| NCT05141474 | Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors(NEXTGENTIL-ACT) | recruiting | Early Phase 1 | 10 | Vall d'Hebron Institute of OncologyOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06614751 | A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway | not yet recruiting | Phase 1 | 112 | Danatlas Pharmaceuticals Co., LtdINDUSTRY | 1 | Sep 27, 2024 | clinicaltrials |
| NCT05773937 | A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors | recruiting | Phase 1 | 40 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06592417 | To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors | recruiting | Phase 1 | 140 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05579275 | Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors | recruiting | Early Phase 1 | 24 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05539677 | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research(REGATA) | recruiting | — | 1,000 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 6, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 18, 2025source: clinicaltrials